Mahal Jeetinder Singh — SEC Form 4 filings
SEC reporting owner CIK 1882877. 9 Form 4 filings on record with FilingPulse; latest filed 2026-02-10.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-20 to 2026-02-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 3,600 shares, $84,534 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 900 shares @ $26.44 ($23,792) in Jasper Therapeutics, Inc., filed 2024-03-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | CEO and President, Director | 9 | — | 4 legs · 3,600 sh · $84,534 | 13 |
Form 4 filings — Mahal Jeetinder Singh
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-10 | 4 | Jasper Therapeutics, Inc. (JSPR) | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Jasper Therapeutics, Inc. (JSPR) | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Jasper Therapeutics, Inc. (JSPR) | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | Jasper Therapeutics, Inc. (JSPR) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | Jasper Therapeutics, Inc. (JSPR) | Option exercise (M): 900 @ $7.10 · Sale (S): 900 @ $22.11 · Option exercise (M): 900 (derivative) @ $0 | EDGAR |
| 2024-09-12 | 4 | Jasper Therapeutics, Inc. (JSPR) | Option exercise (M): 900 @ $7.10 · Sale (S): 900 @ $21.23 · Option exercise (M): 900 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | Jasper Therapeutics, Inc. (JSPR) | Option exercise (M): 900 @ $7.10 · Sale (S): 900 @ $24.16 · Option exercise (M): 900 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | Jasper Therapeutics, Inc. (JSPR) | Option exercise (M): 900 @ $7.10 · Sale (S): 900 @ $26.44 · Option exercise (M): 900 (derivative) @ $0 | EDGAR |
| 2024-02-20 | 4 | Jasper Therapeutics, Inc. (JSPR) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1882877 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →